Increasing the Potential of the Auristatin Cancer-Drug Family by Shifting the Conformational Equilibrium

[Image: see text] Monomethyl auristatin E and monomethyl auristatin F are widely used cytotoxic agents in antibody–drug conjugates (ADCs), a group of promising cancer drugs. The ADCs specifically target cancer cells, releasing the auristatins inside, which results in the prevention of mitosis. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokka, Iris K., Ekholm, Filip S., Johansson, Mikael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750905/
https://www.ncbi.nlm.nih.gov/pubmed/31199662
http://dx.doi.org/10.1021/acs.molpharmaceut.9b00437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750905/
https://www.ncbi.nlm.nih.gov/pubmed/31199662
http://dx.doi.org/10.1021/acs.molpharmaceut.9b00437

Ejemplares similares